United States · FDA National Drug Code directory
pazopanib
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 13668-735_6b6119a9-55d1-4a4d-a0aa-d287024a9ed8
- Product NDC
- 13668-735
- Form
- TABLET, FILM COATED
- Composition / generic term
- pazopanib hydrochloride
- Labeler
- Torrent Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250904
- Source listing expiry
- 20271231
Source-listed ingredients
- PAZOPANIB HYDROCHLORIDE — 400 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED in 1 BOTTLE (13668-735-30) · 13668-735-30
- 60 TABLET, FILM COATED in 1 BOTTLE (13668-735-60) · 13668-735-60
- 90 TABLET, FILM COATED in 1 BOTTLE (13668-735-90) · 13668-735-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →